Evaluation of the impact of alcohol control policies on morbidity and mortality in Lithuania and other Baltic states
Project Number5R01AA028224-05
Contact PI/Project LeaderREHM, JUERGEN T Other PIs
Awardee OrganizationCENTRE FOR ADDICTION AND MENTAL HEALTH
Description
Abstract Text
PROJECT SUMMARY/ABSTRACT
Alcohol use has been identified as a major risk factor for the global burden of death, disease and
injury. Given the high levels of overall volume of alcohol use, detrimental drinking patterns, and high
levels of alcohol-attributable mortality and burden of disease, Lithuania recently implemented three of
the most effective alcohol control policies within a short time span: increase in taxation, reduction of
availability of alcoholic beverages, and a ban on advertisement. For the first time ever, the
implementation of these three best practices in alcohol control policy allows for an evaluation of their
combined effect on total amount of alcohol consumed, as well as alcohol-attributable hospitalizations,
deaths and violence in the subpopulations targeted by these policies. It also allows for a
comprehensive economic evaluation of the return on investment – that is, a comparison of the cost of
implementation and the economic benefits due to a reduction in alcohol-attributable hospitalizations,
deaths and violence – which has never been done before. Accordingly, the proposed study intends
to measure the effectiveness and economic gains of the interventions implemented in Lithuania, and
to compare Lithuania to two other Baltic countries (Estonia and Latvia) to ensure that any changes
observed within the country were not part of any regional trends that were independent of the
interventions. The proposed study will use a mix of different quantitative and qualitative methods,
based on high-quality data. Not only is this the first time that the three most effective alcohol control
policies have been implemented almost simultaneously, but, given the characteristics of Lithuania,
the effects of such interventions can be generalized to other high-income countries, such as the
United States. What we learn from the proposed study will inform and enhance our ability to prevent
alcohol-attributable deaths, diseases and injuries in the United States, including but not limited to the
so-called deaths of despair (i.e., liver cirrhosis, suicide and poisoning). The proposed proposal
involves a number of decision-makers and alcohol policy stakeholders, who will be intricately involved
in the interpretation, publishing and publicizing the findings.
Public Health Relevance Statement
PROJECT NARRATIVE
For the first time ever, Lithuania has implemented all three of the World Health Organization’s “best
buys” for alcohol control policy within a relatively short timeframe, allowing for an evaluation of their
combined effect on health, crime, and violence, as well as an evaluation comparing the costs of their
implementation to the return on investment via the reduction in hospitalization rates. Lithuania will be
compared to surrounding countries in the eastern part of the European Union, to ensure that any
changes observed within the country were not part of a regional trend independent of the “best buy”
interventions. The proposed study will provide findings, never before possible, that are generalizable
to other high-income countries, such as the United States.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AdultAdvertisementsAgeAlcohol consumptionAlcoholic BeveragesAlcoholsBaltic StatesCessation of lifeCharacteristicsCompensationConsumptionCountryCrimeDataDiseaseEastern EuropeEconomicsEstoniaEuropeanEuropean UnionEvaluationExpenditureFutureGovernmentHealthHigh PrevalenceHospitalizationHourImpact evaluationIncomeInjuryInterventionInvestmentsLatviaLearningLife ExpectancyLinkLithuaniaLiver CirrhosisMeasuresMorbidity - disease rateOutcomePatternPoisoningPoliciesPopulationPopulation InterventionPublishingQualitative MethodsRisk FactorsSalesSocioeconomic StatusSuicideSumTarget PopulationsTaxationTaxesTimeUnited StatesViolenceWorld Health Organizationalcohol measurementalcohol preventionattributable mortalitybinge drinkingburden of illnesscostcost comparisondrinkingeconomic evaluationeffectiveness measurehospitalization ratesimplementation costimprovedminimum drinking agemortalitypublic policy on alcoholsextrendyoung adult
National Institute on Alcohol Abuse and Alcoholism
CFDA Code
273
DUNS Number
207855271
UEI
YHQGDQJ58Q17
Project Start Date
10-April-2020
Project End Date
31-March-2026
Budget Start Date
01-April-2024
Budget End Date
31-March-2026
Project Funding Information for 2024
Total Funding
$447,276
Direct Costs
$414,321
Indirect Costs
$32,955
Year
Funding IC
FY Total Cost by IC
2024
National Institute on Alcohol Abuse and Alcoholism
$447,276
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AA028224-05
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AA028224-05
Patents
No Patents information available for 5R01AA028224-05
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AA028224-05
Clinical Studies
No Clinical Studies information available for 5R01AA028224-05
News and More
Related News Releases
No news release information available for 5R01AA028224-05
History
No Historical information available for 5R01AA028224-05
Similar Projects
No Similar Projects information available for 5R01AA028224-05